| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 333 | 265 | +25.5% |
| EBITDA | 82.3 | 47.8 | +72.1% |
| EBITDA margin | 24.7% | 18.0% | +6.7 pts |
| Profit before tax | 86.8 | 51.4 | +68.7% |
| Net profit | 70.2 | 42.3 | +65.9% |
| EPS | ₹5.37 | ₹3.09 | +73.8% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 5,102 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 505 | 389 | 372 | 608 | 589 | ||
| 4,597 | — | — | — | — | ||
| 1,307 | 1,165 | 965 | 984 | 961 | ||
| — | +20.7% | −2.0% | +2.4% | — | ||
| 298 | 221 | 127 | 155 | 141 | ||
| 22.8% | 19.0% | 13.2% | 15.8% | 14.7% | ||
| 282 | 206 | 117 | 145 | 133 | ||
| 251 | 190 | 125 | 155 | 139 | ||
| 19.2% | 16.3% | 13.0% | 15.8% | 14.5% | ||
| ₹19.21 | ₹14.56 | ₹9.59 | ₹11.90 | ₹10.66 | ||
| — | +51.8% | −19.4% | +11.6% | — | ||
| — | 197 | 65.1 | 116 | 101 | ||
| — | −33.5 | −5.8 | −4.8 | −6.4 | ||
| 163 | 163 | 59.3 | 112 | 95.0 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 5,101.9 | |
| - Cash, Equiv & ST Investments | 589.0 | 608.3 | 371.6 | 388.6 | 504.6 | |
| Enterprise Value | — | — | — | — | 4,597.3 | |
| Revenue | 960.9 | 984.1 | 964.8 | 1,164.7 | 1,307.2 | |
| Growth %, YoY | — | +2.4 | -2.0 | +20.7 | — | |
| EBITDA | 141.2 | 155.3 | 127.4 | 220.9 | 298.3 | |
| Margin % | 14.70 | 15.78 | 13.21 | 18.97 | 22.82 | |
| EBIT | 132.7 | 145.4 | 117.3 | 205.6 | 281.6 | |
| Net Income | 139.2 | 155.4 | 125.3 | 190.2 | 250.9 | |
| Margin % | 14.49 | 15.79 | 12.98 | 16.33 | 19.19 | |
| EPS, Adj (current shares) | 10.66 | 11.90 | 9.59 | 14.56 | 19.21 | |
| Growth %, YoY | — | +11.6 | -19.4 | +51.8 | — | |
| Cash from Operations | 101.5 | 116.3 | 65.1 | 196.9 | — | |
| Capital Expenditures | -6.4 | -4.8 | -5.8 | -33.5 | — | |
| Free Cash Flow | 95.0 | 111.5 | 59.3 | 163.4 | 163.4 | |
Prices at the previous close · figures from the company's filings with NSE
Bajaj Consumer Care (NSE: BAJAJCON) had a market capitalisation of ₹5,102 crore at the previous close (₹390.60 a share), a PE ratio of 20.3 on the last four quarters' profit and a price-to-book ratio of 5.68. In FY26 its consolidated net profit was ₹190 crore on revenue of ₹1,165 crore; in Q2 FY27 (July–September 2026) it was ₹70.2 crore, up 65.9% year on year. It had no borrowings on 30 September 2026. Promoters held 42.97% of the shares on 30 September 2026.
Bajaj Consumer Care's PE ratio is 20.3 at the previous close (₹390.60 a share): a market capitalisation of ₹5,102 crore divided by consolidated net profit of ₹251 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit (₹190 crore) it is 26.8.
Bajaj Consumer Care's price-to-book (PB) ratio is 5.68 at the previous close: a market capitalisation of ₹5,102 crore divided by shareholders' equity (book value) of ₹898 crore on 30 September 2026. That is a book value of ₹68.72 per share against a share price of ₹390.60.
Bajaj Consumer Care's book value per share was ₹68.72 on 30 September 2026: shareholders' equity of ₹898 crore divided by the 13.06 crore shares in issue, up 39.2% from ₹49.39 a year earlier. The share price at the previous close was ₹390.60.
Bajaj Consumer Care's market capitalisation was ₹5,102 crore at the previous close: 13.06 crore shares at ₹390.60 each.
Yes. Bajaj Consumer Care had no borrowings on 30 September 2026 (consolidated balance sheet), and it held ₹527 crore of cash, bank balances and current investments.
Bajaj Consumer Care's basic earnings per share (EPS) were ₹14.21 in FY26, against ₹9.03 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹18.98.
Bajaj Consumer Care's debt-to-equity ratio was 0.00 on 30 September 2026: no borrowings against total equity of ₹898 crore. A year earlier, on 30 September 2025, it was 0.00.
Bajaj Consumer Care's net worth — shareholders' equity in its consolidated balance sheet — was ₹898 crore on 30 September 2026, up 39.2% from ₹645 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹5,102 crore at the previous close.
Promoters held 42.97% of Bajaj Consumer Care on 30 September 2026, unchanged from the previous quarter and up 2.02 percentage points from 40.95% a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Bajaj Consumer Care's return on equity (ROE) was 25.3% and its return on capital employed (ROCE) was 26.9%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 15.9% and ROCE 14.7%.
On 30 September 2026, Bajaj Consumer Care's shares were held by promoters 42.97%, foreign portfolio investors (FII/FPI) 16.40%, domestic institutions (DII) 14.89% (including mutual funds at 13.52%) and retail and other non-institutional investors 25.75%. Over the year, FII holding was up 6.28 percentage points from 10.12% and DII holding was down 0.37 percentage points from 15.26%.
In FY26, Bajaj Consumer Care earned net profit of ₹190 crore on revenue of ₹1,165 crore, against ₹1.9 crore on ₹102 crore for JHS Svendgaard Laboratories. Bajaj Consumer Care's operating margin was 17.7% (JHS Svendgaard Laboratories −4.8%) and its return on equity 25.3% (JHS Svendgaard Laboratories −1.1%).
In FY26, Bajaj Consumer Care generated ₹197 crore of cash from operations and spent ₹33.5 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹163 crore. In FY25 it was ₹59.3 crore.
Bajaj Consumer Care's latest results are for Q2 FY27 (July–September 2026), filed on 14 October 2026: consolidated net profit ₹70.2 crore, up 65.9% from ₹42.3 crore in Q2 FY26; revenue from operations ₹333 crore, up 25.5% year on year.
In FY26 (April 2025–March 2026), Bajaj Consumer Care's consolidated net profit was ₹190 crore, up 51.8% from ₹125 crore in FY25, on revenue from operations of ₹1,165 crore (up 20.7%). Over three years, from FY23, net profit was up 36.6%.
Bajaj Consumer Care has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
On FY26 consolidated figures, against JHS Svendgaard Laboratories: Bajaj Consumer Care's operating margin of 17.7% is the higher of the two (JHS Svendgaard Laboratories −4.8%; peer average −4.8%); its return on equity of 25.3% is the higher of the two (JHS Svendgaard Laboratories −1.1%; peer average −1.1%); its revenue growth over three years of 6.6% a year is the higher of the two (JHS Svendgaard Laboratories 1.9% a year; peer average 1.9% a year).
From Bajaj Consumer Care's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.